A. N. Orekhov

发表

The role of endoplasmic reticulum stress in atherosclerosis

A. Orekhov, I. Sobenin, A. M. Markin, 2020, Complex Issues of Cardiovascular Diseases.

[The biological activity of high-density lipoprotein fractions and their role in the development of cardiovascular diseases].

A. Orekhov, A. Kontush, J. Chapman, 2016, Terapevticheskii arkhiv.

Human plasma trans-sialidase causes atherogenic modification of low density lipoprotein.

V. Tertov, A. Orekhov, N. Bovin, 2001, Atherosclerosis.

Vascular Health and Risk Management Dovepress Ldl Electronegativity Index: a Potential Novel Index for Predicting Cardiovascular Disease

Y. Bobryshev, E. Ivanova, A. N. Orekhov, 2022 .

[Atherogenesis in human - clinical aspects of circulating immune complexes].

A. Orekhov, V. Karagodin, A. Sergeeva, 2016, Klinicheskaia meditsina.

Three types of naturally occurring modified lipoproteins induce intracellular lipid accumulation due to lipoprotein aggregation.

V. Tertov, A. Orekhov, A. Yaroslavov, 1992, Circulation research.

Multiple-modified desialylated low density lipoproteins that cause intracellular lipid accumulation. Isolation, fractionation and characterization.

V. Tertov, A. Orekhov, T. Nikkari, 1992, Laboratory investigation; a journal of technical methods and pathology.

Modification of low density lipoprotein by desialylation causes lipid accumulation in cultured cells: discovery of desialylated lipoprotein with altered cellular metabolism in the blood of atherosclerotic patients.

V. Tertov, A. Orekhov, I. Mikhailenko, 1989, Biochemical and biophysical research communications.

Contents of mRNAs encoding endosome/lysosome components in normal human aorta and in stage ii of atherogenesis: a hidden regulation

A. Orekhov, I. Sobenin, A. N. Smirnov, 2011, Biochemistry (Moscow).

Lipid composition of circulating multiple-modified low density lipoprotein

A. Melnichenko, E. Zakiev, V. Sukhorukov, 2016, Lipids in Health and Disease.